Human Microbiome Market Scope And Analysis

  • Report Code : TIPBT00002233
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 188
Buy Now

Human Microbiome Market Scope, Growth, Size and Share by 2028

Buy Now

Human Microbiome Market Report Human Microbiome Market Size and Share Human Microbiome Market Scope and Analysis

Human Microbiome Market Report Scope

Report Attribute Details
Market size in 2021 US$ 718.95 Million
Market Size by 2028 US$ 2,921.68 Million
Global CAGR (2021 - 2028) 22.2%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Probiotics
  • Foods
  • Prebiotics
  • Medical Foods
  • Diagnostic Device
  • Drugs and Supplements
By Disease
  • Obesity
  • Diabetes
  • Autoimmune Disorders
  • Cancer
  • Mental Disorders
By Application
  • Therapeutics and Diagnostics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Rebiotix Inc
  • Yakult Honsha Co Ltd
  • Synthetic Biologics Inc
  • DuPont
  • MaaT Pharma
  • Eligo Bioscience
  • Merck Co Inc
  • AOBiome LLC
  • Kaleido

    • Human Microbiome Market – by Product

    • Probiotics 
    • Foods
    • Prebiotics
    • Medical Foods
    • Diagnostic Devices
    • Drugs
    • Supplements

    Human Microbiome Market – by Disease  

    • Obesity
    • Diabetes
    • Autoimmune Disorders
    • Cancer
    • Mental Disorders
    • Others

     Human Microbiome Market – by Application   

    • Therapeutics
    • Diagnostics

    Human Microbiome Market – by Geography

    • North America

      • US
      • Canada
      • Mexico

    • Europe

      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe

    • Asia Pacific (APAC)

      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of Asia Pacific

    • Middle East and Africa (MEA)

      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of Middle East and Africa

    • South and Central America (SCAM)

      • Brazil
      • Argentina
      • Rest of South and Central America

    Company Profiles

    • Rebiotix Inc.
    • Yakult Honsha Co., Ltd.
    • Synthetic Biologics Inc.
    • DuPont
    • MaaT Pharma
    • Eligo Bioscience
    • Merck & Co. Inc
    • AOBiome LLC
    • Kaleido
    • Seres Therapeutics